Jacob Halling won Young Fundraiser of the Year at Muscular Dystrophy's Stronger Together Awards for fundraising in support of ...

Entos and L-CMD Foundation partner to develop potentially curative gene therapy for L-CMD, a rare, fatal, childhood disease.

At Sarepta Therapeutics, we’ve seen it all. Here are the questions I believe we should be asking to move forward in Duchenne ...

Jacob Halling won Young Fundraiser of the Year at Muscular Dystrophy's Stronger Together Awards for fundraising in support of ...

The Speak Foundation today announced the launch of the LGMD Centers of Excellence, a national network of leading academic ...

KROS sharpens focus on rinvatercept as a phase II DMD study looms in 2026, shifting the story toward execution and high-stakes clinical catalysts.

ETHealthworld.com brings latest muscular dystrophy news, views and updates from all top sources for the Indian Health ...

Osmond enjoyed the support of his siblings and his own children as he reconfigured his life ...

Alan Osmond navigated his multiple sclerosis journey with the support of his family. The oldest member of The Osmonds, who ...

Scientists sum up the evidence—or lack thereof—for the most popular peptides hyped for athletic performance and recovery.

The MarketWatch News Department was not involved in the creation of this content.-- ImmunoForge's LMT15 Platform combines high BBB permeability with proprietary long-acting ELP te ...

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced the presentation of data from its Phase 3 ...